Eros International Plc (EROS) 35.78 $EROS Eros

New Post Public Reply Private Reply Replies (0) Message Board

Aug 1, 2015 at 3:00 AM

Eros International Plc (EROS) 35.78 $EROS

Eros International Plc (EROS) Jumps: Stock Moves 7.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 21, 8:32AM CDT
Eros International Plc (EROS) was a big mover last session, as the company saw its shares rise nearly 8% on the day.
EROS: 35.78 (+0.77), IMAX: 37.41 (+0.32)

Eros International Announces Official Marketing Launch for ErosNow
Business Wire - Thu Jul 16, 7:30AM CDT
Eros International Plc (NYSE:EROS) ("Eros" or the "Company"

, a leading global company in the Indian film entertainment industry, today announced the official marketing launch of ErosNow, the company's dedicated online entertainment portal, as well as its upcoming content line-up of exclusive movie premieres and originals.
EROS: 35.78 (+0.77)

Why Shares of Eros International Plc Rose Today
Timothy Green, The Motley Fool - Motley Fool - Fri Jul 10, 12:35PM CDT
What: Shares of Indian film production and distribution company Eros International rose on Friday after the company beat analyst estimates when it reported its fiscal fourth quarter earnings. By 11:30 AM on Friday, the stock was up about 9.5%,...
EROS: 35.78 (+0.77)

Eros International (EROS) in Focus: Stock Jumps 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 09, 8:18AM CDT
Eros International Plc (EROS) was a big mover last session, as the company saw its shares rise nearly 8% on the day.
EROS: 35.78 (+0.77), IMAX: 37.41 (+0.32)

Eros Int'l. (EROS) Stock Closed Higher Following Earnings Beat
at The Street - Wed Jun 10, 3:33PM CDT
Eros Int'l. (EROS) shares climbed after the company beat analysts' fourth quarter earnings and revenue expectations.
EROS: 35.78 (+0.77)

Eros International up 3% following Q4 earnings beat
Seeking Alpha - at Seeking Alpha - Wed Jun 10, 2:37PM CDT

EROS: 35.78 (+0.77)

Eros International's (EROS) CEO Jyoti Deshpande on Q4 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Jun 10, 10:13AM CDT

EROS: 35.78 (+0.77)

CORRECTING and REPLACING Eros International Plc reaches $100 million Adjusted EBITDA for Fiscal Year 2015
Business Wire - Wed Jun 10, 9:29AM CDT
--Financial Highlights
EROS: 35.78 (+0.77)

Eros posts 4Q profit
Automated Insights - Wed Jun 10, 8:48AM CDT
MUMBAI, India (AP) _ Eros International PLC (EROS) on Wednesday reported fiscal fourth-quarter earnings of $17.4 million.
EROS: 35.78 (+0.77)

Eros International beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Jun 10, 8:41AM CDT

EROS: 35.78 (+0.77)

Eros International Plc reaches $100 million Adjusted EBITDA for Fiscal Year 2015
Business Wire - Wed Jun 10, 8:30AM CDT
--Financial Highlights
EROS: 35.78 (+0.77)

REPEAT/Gabelli & Company's 7th Annual Movie & Entertainment Conference
Business Wire - Wed Jun 10, 6:30AM CDT
Gabelli & Company will host its 7th Annual Movie & Entertainment Conference on June 11, 2015 in New York City. This event will feature presentations, fireside chats, and one-on-one meetings with senior management of leading entertainment, movie exhibition, and media companies. Institutional investors should contact their Gabelli & Company sales representative to register.
NCMI: 15.50 (+0.19), CGX.TO: 47.64 (-0.56), AMCX: 84.22 (+0.50), GBL: 68.66 (+1.87), MCS: 20.96 (+0.55), RGC: 20.60 (+0.78), CNK: 39.46 (+0.29), IMAX: 37.41 (+0.32), VDTH: 12.79 (-0.06), LGF: 39.18 (+0.16), FOXA: 34.49 (+0.45), RHP: 57.18 (+1.25), CKEC: 25.05 (+0.45), EPR: 57.12 (+0.92), EROS: 35.78 (+0.77), TV: 34.86 (+0.61)

Eros International to Present at Upcoming Investor Conferences
Business Wire - Fri Jun 05, 7:45AM CDT
Eros International Plc (NYSE:EROS) ("Eros"

, a leading global company in the Indian film entertainment industry, announced today that Group Chief Financial Officer and President - North America, Prem Parameswaran and Group Chief Corporate and Strategy Officer, Mark Carbeck are scheduled to attend several upcoming conferences, including:
EROS: 35.78 (+0.77)

Eros International: Expect Further Upside In Current Financial Year
Economics Fanatic - at Seeking Alpha - Thu Jun 04, 9:25AM CDT

EROS: 35.78 (+0.77)

Eros International Plc to Report Fourth Quarter and Fiscal Year Ended 2015 Results on June 10, 2015
Business Wire - Fri May 29, 11:19AM CDT
Eros International Plc (NYSE:EROS) ("Eros"

, a leading global company in the Indian film entertainment industry, announced today that it will issue a press release to report its results for the fiscal fourth quarter and full year ended 2015 before the market opens on Wednesday, June 10, 2015. The Company will host a conference call that day at 8:30 AM ET.
EROS: 35.78 (+0.77)

Prem Parameswaran Appointed Group Chief Financial Officer and President - North America of Eros International Plc
Business Wire - Thu May 28, 7:30AM CDT
Eros International, Plc (NYSE:EROS) ("Eros"

, a leading global company in the Indian film entertainment industry, announced today that it will appoint Mr. Prem Parameswaran Group Chief Financial Officer of Eros International, Plc and President - North America, a newly created position, in the coming weeks following a brief transition period. Mr. Parameswaran will succeed Mr. Andrew Heffernan as Group Chief Financial Officer who will be taking a leave of absence from the Company in June.
EROS: 35.78 (+0.77)

Rate Cut Can Trigger Rally For Indian Equities
Economics Fanatic - at Seeking Alpha - Mon May 18, 10:20AM CDT

IBN: 10.07 (+0.47), INXX: 12.46 (+0.03), INCO: 36.15 (+0.67), EROS: 35.78 (+0.77)

Eros International Announces Deal with Major Chinese Film and Entertainment Companies to Produce and Distribute Sino-Indian Films
Business Wire - Mon May 18, 7:30AM CDT
Eros International, Plc (NYSE:EROS) ("Eros"

, a leading global company in the Indian film entertainment industry, announced landmark deals with three major Chinese state owned film and entertainment companies to promote, co-produce and distribute Sino-Indian films across all platforms in both the countries.
EROS: 35.78 (+0.77)

Gabelli & Company's 7th Annual Movie & Entertainment Conference
Business Wire - Wed May 06, 6:00AM CDT
Gabelli & Company will host its 7th Annual Movie & Entertainment Conference on June 11, 2015 in New York City. This event will feature presentations, fireside chats, and one-on-one meetings with senior management of leading entertainment, movie exhibition, and media companies. Institutional investors should contact their Gabelli & Company sales representative to register.
NCMI: 15.50 (+0.19), CGX.TO: 47.64 (-0.56), AMCX: 84.22 (+0.50), GBL: 68.66 (+1.87), MCS: 20.96 (+0.55), RGC: 20.60 (+0.78), CNK: 39.46 (+0.29), IMAX: 37.41 (+0.32), VDTH: 12.79 (-0.06), LGF: 39.18 (+0.16), FOXA: 34.49 (+0.45), RHP: 57.18 (+1.25), CKEC: 25.05 (+0.45), EPR: 57.12 (+0.92), EROS: 35.78 (+0.77), TV: 34.86 (+0.61)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Luvme Hair Offers Wig Variety for Winter Fashion

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...